In the context of his recent meeting with Commissioner Margaret A. Hamburg of US-FDA, the Drug Controller General of India (DCGI) reportedly expressed his concern to ‘The Economic Times’ on the ‘objectionable conduct’ of global pharma in new drug trials … Continue reading
“Make Global Pharma Responsible in Homeland for Objectionable Conduct in Clinical Trials Elsewhere”
Reply